177 related articles for article (PubMed ID: 34822913)
1. Corticotropin-releasing factor receptor 1 (CRF-R1) antagonists: Promising agents to prevent visceral hypersensitivity in irritable bowel syndrome.
Lv Y; Wen J; Fang Y; Zhang H; Zhang J
Peptides; 2022 Jan; 147():170705. PubMed ID: 34822913
[TBL] [Abstract][Full Text] [Related]
2. CRF1 receptors as a therapeutic target for irritable bowel syndrome.
Martinez V; Taché Y
Curr Pharm Des; 2006; 12(31):4071-88. PubMed ID: 17100612
[TBL] [Abstract][Full Text] [Related]
3. Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.
Labus JS; Hubbard CS; Bueller J; Ebrat B; Tillisch K; Chen M; Stains J; Dukes GE; Kelleher DL; Naliboff BD; Fanselow M; Mayer EA
Gastroenterology; 2013 Dec; 145(6):1253-61.e1-3. PubMed ID: 23954313
[TBL] [Abstract][Full Text] [Related]
4. From Hans Selye's discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases.
Taché Y; Brunnhuber S
Ann N Y Acad Sci; 2008 Dec; 1148():29-41. PubMed ID: 19120089
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.
Nozu T; Okumura T
J Gastroenterol; 2015 Aug; 50(8):819-30. PubMed ID: 25962711
[TBL] [Abstract][Full Text] [Related]
6. Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract.
Tache Y; Larauche M; Yuan PQ; Million M
Curr Mol Pharmacol; 2018; 11(1):51-71. PubMed ID: 28240194
[TBL] [Abstract][Full Text] [Related]
7. Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.
Buckley MM; O'Halloran KD; Rae MG; Dinan TG; O'Malley D
J Physiol; 2014 Dec; 592(23):5235-50. PubMed ID: 25260633
[TBL] [Abstract][Full Text] [Related]
8. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
J Endocrinol; 2018 Nov; 239(2):241-252. PubMed ID: 30139928
[TBL] [Abstract][Full Text] [Related]
9. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?
Sweetser S; Camilleri M; Linker Nord SJ; Burton DD; Castenada L; Croop R; Tong G; Dockens R; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1299-306. PubMed ID: 19342506
[TBL] [Abstract][Full Text] [Related]
10. Visceral hypersensitivity in irritable bowel syndrome.
Kanazawa M; Hongo M; Fukudo S
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
J Gastroenterol; 2017 Jan; 52(1):72-80. PubMed ID: 27075754
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor and the brain-gut motor response to stress.
Taché Y; Martinez V; Million M; Rivier J
Can J Gastroenterol; 1999 Mar; 13 Suppl A():18A-25A. PubMed ID: 10202204
[TBL] [Abstract][Full Text] [Related]
13. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome.
Taché Y; Martinez V; Million M; Maillot C
Eur J Surg Suppl; 2002; (587):16-22. PubMed ID: 16144197
[TBL] [Abstract][Full Text] [Related]
14. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
Fukudo S
J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
[TBL] [Abstract][Full Text] [Related]
15. Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia.
Taché Y
Neurogastroenterol Motil; 2015 Jan; 27(1):1-6. PubMed ID: 25557223
[TBL] [Abstract][Full Text] [Related]
16. The newly developed CRF1-receptor antagonists, NGD 98-2 and NGD 9002, suppress acute stress-induced stimulation of colonic motor function and visceral hypersensitivity in rats.
Million M; Zhao JF; Luckey A; Czimmer J; Maynard GD; Kehne J; Hoffman DC; Taché Y
PLoS One; 2013; 8(9):e73749. PubMed ID: 24040053
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats.
Greenwood-Van Meerveld B; Johnson AC; Cochrane S; Schulkin J; Myers DA
Neurogastroenterol Motil; 2005 Jun; 17(3):415-22. PubMed ID: 15916629
[TBL] [Abstract][Full Text] [Related]
18. Peripheral apelin mediates visceral hypersensitivity and impaired gut barrier in a rat irritable bowel syndrome model.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Neuropeptides; 2022 Aug; 94():102248. PubMed ID: 35526468
[TBL] [Abstract][Full Text] [Related]
19. Peripheral α-helical CRF (9-41) does not reverse stress-induced mast cell dependent visceral hypersensitivity in maternally separated rats.
van den Wijngaard RM; Stanisor OI; van Diest SA; Welting O; Wouters MM; de Jonge WJ; Boeckxstaens GE
Neurogastroenterol Motil; 2012 Mar; 24(3):274-82, e111. PubMed ID: 22129370
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications.
Larauche M; Kiank C; Tache Y
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7(Suppl 7):33-46. PubMed ID: 20388944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
